Sign In
Buy IQV
$182.05
+1.41 (+0.781%)
At Close: Jun 03, 2026
IQVIA: I Would Stay Away Until Debt Issues Are Resolved
06:33am, Sunday, 12'th Nov 2023
IQVIA is a global provider of contract research services and data analytics for the healthcare industry. The company helps clients drive healthcare forward by providing insights and solutions to impro
IQVIA Holdings (IQV) Q3 Earnings Surpass Estimates
09:46am, Wednesday, 01'st Nov 2023
IQVIA Holdings (IQV) came out with quarterly earnings of $2.49 per share, beating the Zacks Consensus Estimate of $2.46 per share. This compares to earnings of $2.48 per share a year ago.
IQVIA (IQV) to Report Q3 Earnings: What's in the Offing?
12:02pm, Thursday, 26'th Oct 2023
IQVIA's (IQV) revenues are likely to increase year over year on the back of improving segmental performance.
4 Medical Product Stocks Set to Outpace Q3 Earnings Estimates
08:16am, Thursday, 19'th Oct 2023
Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EW, PODD, DXCM and IQV are poised ahead of their earnings release.
IQVIA to Announce Third-Quarter 2023 Results on November 1, 2023
04:15pm, Monday, 09'th Oct 2023
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2023 financial results before the market opens on Wednesday, November 1, 202
IQVIA (IQV) and argenx Partner to Advance Autoimmune Care
09:46am, Thursday, 05'th Oct 2023
IQVIA (IQV) and argenx expand collaboration to advance rare autoimmune treatments through innovative pharmacovigilance.
Court strikes down federal rule that sharply increased prescription costs for many patients
02:56pm, Monday, 02'nd Oct 2023
A federal court on Friday struck down a rule that sharply increased out-of-pocket prescription costs for many patients with complex conditions.
Here's Why Investors Should Retain IQVIA (IQV) Stock Now
12:47pm, Friday, 08'th Sep 2023
An addressable market size and strong healthcare-specific global IT infrastructure boost IQVIA (IQV).
IQVIA CEO Ari Bousbib to Speak at Morgan Stanley Annual Global Healthcare Conference on September 12, 2023
08:30am, Friday, 01'st Sep 2023
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Morgan Stanley An
IQVIA (IQV) Up 2.5% Since Last Earnings Report: Can It Continue?
12:48pm, Thursday, 31'st Aug 2023
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
3 Biotech Stocks That Wall Street Analysts Can't Get Enough Of
08:54am, Wednesday, 30'th Aug 2023
This year has not been kind to biotech stocks, as the sector's most popular ETF, the iShares Biotechnology ETF (NASDAQ: IBB ), has fallen about 3% so far in 2023. Investors are probably worried about
IQVIA (IQV) Stock Improves 8% in Three Months: Here's How
03:47pm, Friday, 25'th Aug 2023
IQVIA (IQV) aims at market expansion through innovation and service improvements.
IQVIA Holdings' (IQV) Q2 Earnings Beat Estimates, Decline Y/Y
02:10pm, Tuesday, 01'st Aug 2023
IQVIA Holdings (IQV) second-quarter 2023 revenues improve year over year.
IQVIA (IQV) Reports Q2 Earnings: What Key Metrics Have to Say
11:55am, Tuesday, 01'st Aug 2023
Although the revenue and EPS for IQVIA (IQV) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street esti
IQVIA Holdings (IQV) Surpasses Q2 Earnings and Revenue Estimates
09:40am, Tuesday, 01'st Aug 2023
IQVIA Holdings (IQV) came out with quarterly earnings of $2.43 per share, beating the Zacks Consensus Estimate of $2.37 per share. This compares to earnings of $2.44 per share a year ago.
